Real Sociedad announced that David Silva has tested positive for COVID-19.© Twitter
Midfielder David Silva has tested positive for COVID-19, his new club Real Sociedad has announced. The former Manchester City player is now under isolation and is currently asymptomatic. “Real Sociedad confirms that David Silva has tested positive in the PCR test at the Policlinica Gipuzkoa. This is the second one test that the new Real Sociedad player has taken in the final 72 hours, the first of which took place on Friday in Las Palmas de Gran Canaria and the result was once negative,” Real Sociedad said in an official commentary.
“David Silva travelled on a steady flight to Bilbao and arrived in San Sebastian. The second one test was once carried out, as indicated in the protocol for returning to activity, the result being positive. All the way through these first hours in San Sebastian, David Silva has not had the possibility to go to Zubieta or greet his new colleagues. The player is already lonely and has been asymptomatic always. The case has been communicated to the competent health authorities,” the club added.
Real Sociedad informs that @21LVA has tested positive for COVID-19 in the test carried out at Policlnica Gipuzkoa. The player is asymptomatic and is self-isolating.#AurreraReala pic.twitter.com/5Rs8gamWsT
— Real Sociedad (@RealSociedadEN) August 31, 2020
Recently, Silva left Manchester City after 10 years and joined the Spanish club Real Sociedad. Silva’s return to Spain came via a free transfer.
Silva had made 436 appearances for Manchester City over 10 seasons. He won four Premier League titles, two FA Cups, five League Cups, and three Community Shields all over his time with the club.
His ultimate appearance for the club came in the Champions League quarter-final against Lyon in Lisbon.
Final month, City had also announced their intention to honour the midfielder with a statue out of doors the Etihad Stadium.
The club will also dedicate a training pitch with a bespoke mosaic to Silva at their City Football Academy.
Topics mentioned in this article